Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC BI 2536 | 755038-02-9 | 99.9% | 50 MG
Supplier: Medchemexpress LLC HY5069850MG
BI 2536 is a dual inhibitor targeting both PLK1 (Polo-like Kinase 1) and BRD4 (Bromodomain-containing protein 4), with IC50 values of 0.83 nM and 25 nM, respectively. It suppresses IFNB (Interferon-beta) gene transcription and exhibits antiproliferative activity against various human cancer cell lines. This product is intended for research use only.
- Targets PLK1 and BRD4
- High potency (IC50 of 0.83 nM for PLK1 and 25 nM for BRD4)
- Suppresses IFNB gene transcription
- Demonstrated antiproliferative activity against a wide range of human cancer cell lines
- Available in solid form and as a 10 mM solution in DMSO
- Purity of 99.9%
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?